Sucharit Bhakdi, MD & Arne Burkhardt, MD: "On COVID vaccines: why they cannot work, & irrefutable evidence of their causative role in deaths after vaccination"; they could not work; can't hit mucosae

by Paul Alexander

secretory IgA produced by immune cells just underneath mucous membranes that line respiratory & intestinal tract, where virus lands vs IgG & circulating IgA occur in the blood (due to muscle injected)

A fundamental mistake underlying the development of the COVID-19 vaccines was to neglect the functional distinction between the two major categories of antibodies which the body produces in order to protect itself from pathogenic microbes. The first category (secretory IgA) is produced by immune cells (lymphocytes) which are located directly underneath the mucous membranes that line the respiratory and intestinal tract. The antibodies produced by these lymphocytes are secreted through and to the surface of the mucous membranes.

These antibodies are thus on site to meet air-borne viruses, and they may be able to prevent viral binding and infection of the cells. The second category of antibodies (IgG and circulating IgA) occur in the bloodstream. These antibodies protect the internal organs of the body from infectious agents that try to spread via the bloodstream. Vaccines that are injected into the muscle – i.e., the interior of the body – will only induce IgG and circulating IgA, not secretory IgA. Such antibodies cannot and will not effectively protect the mucous membranes from infection by SARS-CoV-2. Thus, the currently observed “breakthrough infections” among vaccinated individuals merely confirm the fundamental design flaws of the vaccines. Measurements of antibodies in the blood can never yield any information on the true status of immunity against infection of the respiratory tract.’